BUSINESS / MARKETS / POLITICS17 November 2026
← Story archive

Business

Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

NYT BusinessSubscription may apply

Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.

Read original reporting ↗

Follow the evidence

Read the original report, then compare company disclosures and the relevant official data. A headline alone does not establish an effect on markets.

Coverage timeline

Published reporting in time order

No additional matched coverage has been archived for this story yet.

This page preserves an attributed headline and brief excerpt. The publisher maintains the original report and any subsequent corrections. Report a classification or link issue →